SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
osteoclast
Journals
13
1
Nutrients
2
regulatory toxicology and pharmacology : rtp
3
European journal of pharmacology
4
food and chemical toxicology : an international journal published for the british industrial biological research association
5
The Journal of pharmacy and pharmacology
6
Frontiers in immunology
7
literature and medicine
8
Journal of the Royal Society, Interface
9
journal of gastroenterology
10
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
11
international journal of toxicology
12
research communications in molecular pathology and pharmacology
13
human & experimental toxicology
Research Groups
0
No Research Group Connected
Bibliographies
56
1
The Challenge of Teaching Essential Immunology Laboratory Skills to Undergraduates in One Month-Experience of an Osteoimmunology Course on TLR Activation.
2
Rash Reading: Rethinking Virginia Woolf's <i>On Being Ill</i>.
3
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
4
Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
5
Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin.
6
Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
7
Glycyrrhizic acid: the assessment of a no effect level.
8
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
9
Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
10
Glycyrrhizic acid in liquorice--evaluation of health hazard.
11
Ameliorates Bone Loss in Ovariectomized Mice and Inhibits Osteoclastogenesis In Vitro.
12
Bioinspired polydopamine and polyphenol tannic acid functionalized titanium suppress osteoclast differentiation: a facile and efficient strategy to regulate osteoclast activity at bone-implant interface.
13
a comparison of osteoblast and osteoclast in vitro co-culture models and their translation for preclinical drug testing applications
14
regulation of osteoclast differentiation by camkⅡδ mediated through creb and erk1/2 signal pathways
15
dendrobium moniliforme exerts inhibitory effects on both receptor activator of nuclear factor kappa-b ligand-mediated osteoclast differentiation in vitro and lipopolysaccharide-induced bone erosion in vivo
16
influence of surface microstructure and chemistry on osteoinduction and osteoclastogenesis by biphasic calcium phosphate discs
17
the model of distributor chain financing based on buy back guarantee contract
18
targeting the metastatic bone microenvironment by micrornas
19
pengaruh kekurangan kalsium pre-postnatal terhadap kepadatan gigi dalam menunjang perawatan ortodontik studi eksperimental laboratoris pada tikus
20
measles virus nucleocapsid protein modulates the signal regulatory protein-β1 (sirpβ1) to enhance osteoclast differentiation in paget's disease of bone
21
coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?
22
Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model.
23
Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro
24
Impairment of bone microstructure and upregulation of osteoclastogenic markers in spontaneously hypertensive rats.
25
Crosstalk between Fas and S1P<inf>1</inf> signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis
26
New methodology for evaluating osteoclastic activity induced by orthodontic load.
27
Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis.
28
Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
29
Parathyroid Hormone Derivative with Reduced Osteoclastic Activity Promoted Bone Regeneration via Synergistic Bone Remodeling and Angiogenesis.
30
Author Correction: Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice (Nature Communications, (2019), 10, 1, (5643), 10.1038/s41467-019-13476-9)
31
Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases.
32
Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis
33
Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss.
34
Murine osteoclastogenesis suppression using conditioned media produced by melanoma or activated and non-activated Jurkat-E6 cells.
35
GIT1 contributes to autophagy in osteoclast through disruption of the binding of Beclin1 and Bcl2 under starvation condition
36
water-soluble fullerene (c60) inhibits the osteoclast differentiation and bone destruction in arthritis
37
promotion of osteoclastogenesis by il-26 in rheumatoid arthritis
38
ferryl hemoglobin inhibits osteoclastic differentiation of macrophages in hemorrhaged atherosclerotic plaques
39
red ginseng extract ameliorates autoimmune arthritis via regulation of stat3 pathway, th17/treg balance, and osteoclastogenesis in mice and human
40
a matrine derivative m54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein s5
41
rank expression and osteoclastogenesis in human monocytes in peripheral blood from rheumatoid arthritis patients
42
infected osteoclastoma of the knee: an unusual presentation
43
bortezomib modulates chit1 and ykl40 in monocyte-derived osteoclast and in myeloma cells
44
modulation of osteoclast interactions with orthopaedic biomaterials
45
pantoprazole decreases cell viability and function of human osteoclasts in vitro
46
bone anabolic effects of soluble si: in vitro studies with human mesenchymal stem cells and cd14+ osteoclast precursors
47
3,3′-diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice
48
osteoclasts and cd8 t cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems
49
triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of il-10 and tgf-β1 by regulatory t cells
50
wedelolactone enhances osteoblastogenesis but inhibits osteoclastogenesis through sema3a/nrp1/plexina1 pathway
51
water extract of magnolia officinalis cortex inhibits osteoclastogenesis and bone resorption by downregulation of nuclear factor of activated t cells cytoplasmic 1
52
therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments
53
physiology and the effect of some drugs on osteoclast
54
the f-actin modulator swap-70 controls podosome patterning in osteoclasts
55
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease
56
Corrigendum to “MicroRNA-25-3p regulates osteoclasts through nuclear factor I X” [Biochem. Biophys. Res. Commun. 522(1) (2020) 74–80, (Biochemical and Biophysical Research Communications (2020) 522(1) (74-80) (S0006291X1932162X), (10.1016/j.bbrc.2019.11.043))